Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10000480B2
公开(公告)日:2018-06-19
Compounds having the following formula I:
or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.
AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20170022192A1
公开(公告)日:2017-01-26
Compounds having the following formula I:
or a stereoisomer or pharmaceutically-acceptable salt thereof, where R
1
, R
2
, R
3
, R
4
, and R
5
are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.
Visible‐Light‐Enabled Ruthenium‐Catalyzed
<i>meta</i>
‐C−H Alkylation at Room Temperature
Visible‐light‐induced ruthenium catalysis has enabled remote C−Halkylations with excellent levels of position control under exceedingly mild conditions at roomtemperature. The metallaphotocatalysis occurred under exogenous‐photosensitizer‐free conditions and features an ample substrate scope. The robust nature of the photo‐induced mild meta‐C−H functionalization is reflected by the broad functional